Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

BALTOPPEN BIO ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 2.8% 2.8%   Bankruptcy risk   4.8% 3.8% 11.4% 7.9% 13.1% 7.1% 16.1% 16.1%   Credit score (0-100)   46 52 21 29 17 33 11 11   Credit rating   BBB BBB BB BB BB BBB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   1,374 1,528 800 216 -24.1 2.8 0.0 0.0   EBITDA   69.2 150 -162 391 -24.7 2.8 0.0 0.0   EBIT   29.7 118 -182 203 -24.7 2.8 0.0 0.0   Pre-tax profit (PTP)   29.7 115.7 -183.0 209.4 -12.7 15.9 0.0 0.0   Net earnings   23.2 90.2 -142.4 163.2 -9.9 12.4 0.0 0.0   Pre-tax profit without non-rec. items   29.7 116 -183 209 -12.7 15.9 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   52.3 20.0 0.0 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   124 214 71.9 235 225 238 158 158   Interest-bearing liabilities   75.2 13.5 18.5 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   704 735 382 316 297 310 158 158   Net Debt   -463 -626 -168 -51.3 -17.2 -36.9 -158 -158     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   1,374 1,528 800 216 -24.1 2.8 0.0 0.0   Gross profit growth   4.3% 11.2% -47.6% -73.1% 0.0% 0.0% -100.0% 0.0%   Employees   3 3 3 1 1 1 0 0   Employee growth %   0.0% 0.0% 0.0% -66.7% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   704 735 382 316 297 310 158 158   Balance sheet change%   -4.5% 4.4% -48.1% -17.2% -5.9% 4.2% -49.1% 0.0%   Added value   69.2 150.0 -162.1 391.3 163.3 2.8 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -79 -65 -40 -188 0 0 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 -1.0 1.0 -1.0 1.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   2.2% 7.7% -22.8% 94.3% 102.5% 100.0% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   4.1% 16.4% -32.4% 61.5% -3.3% 6.0% 0.0% 0.0%   ROI %   14.4% 55.1% -113.7% 131.8% -4.4% 7.9% 0.0% 0.0%   ROE %   20.6% 53.3% -99.5% 106.3% -4.3% 5.4% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   17.6% 29.2% 18.8% 74.4% 75.8% 76.7% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -670.2% -417.0% 103.7% -13.1% 69.7% -1,329.5% 0.0% 0.0%   Gearing %   60.5% 6.3% 25.7% 0.0% 0.0% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 4.7% 13.0% 54.3% 0.0% 0.0% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   1.0 1.3 1.2 3.8 4.0 4.1 0.0 0.0   Current Ratio   1.1 1.4 1.2 3.8 4.0 4.1 0.0 0.0   Cash and cash equivalent   538.6 639.1 186.5 51.3 17.2 36.9 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   71.8 194.3 71.9 222.6 212.7 225.1 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   23 50 -54 391 163 3 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   23 50 -54 391 -25 3 0 0   EBIT / employee   10 39 -61 203 -25 3 0 0   Net earnings / employee   8 30 -47 163 -10 12 0 0